Nonfunctioning and Subclinical Cortisol Secreting Adrenal Incidentalomas and their Association with Metabolic Syndrome: A Systematic Review
- PMID: 31641636
- PMCID: PMC6683688
- DOI: 10.4103/ijem.IJEM_52_19
Nonfunctioning and Subclinical Cortisol Secreting Adrenal Incidentalomas and their Association with Metabolic Syndrome: A Systematic Review
Abstract
Background: A growing body of evidence suggests that nonfunctioning and subclinical cortisol secreting adrenal incidentalomas (AIs) are associated with several components of metabolic syndrome resulting in increased cardiometabolic risk. The long-term metabolic outcome of these AIs is largely unknown and their most appropriate management remains controversial.
Objectives: To undertake a systematic review of the prevalence of cardiometabolic abnormalities in nonfunctioning and subclinical cortisol secreting AIs and long-term outcome of conservative treatment and adrenalectomy.
Methods: MEDLINE, Cochrane Controlled Trials Register, and EMBASE were searched for relevant studies and systematic review was performed. National Institutes of Health (NIH) quality assessment tool for observational cohort and cross-sectional studies was used to assess the risk of bias in the studies.
Results: Of the 65 studies screened, 18 (10 retrospective, 5 prospective, 2 cross-sectional studies, and 1 randomized controlled trial) were included in the systematic review. Prevalence of hypertension (HTN), impaired glucose metabolism, dyslipidaemia, and raised body mass index (BMI) was higher in subclinical cortisol secreting AIs as compared with nonfunctioning AIs. Surgical intervention had a beneficial effect on blood pressure, glucometabolic control, and obesity in patients with subclinical Cushing's syndrome. The results for lipid metabolism were equivocal. There was no significant improvement in cardiometabolic risk factors after adrenalectomy in nonfunctioning AIs. The quality of evidence was found to be low to moderate.
Conclusions: The systematic review demonstrated increased prevalence of components of metabolic syndrome in patients with subclinical cortisol secreting and nonfunctioning AIs. A beneficial role of adrenalectomy on HTN, glucometabolic control, and BMI was observed in patients with subclinical cortisol secreting AIs.
Keywords: Adrenal incidentalomas; metabolic syndrome; subclinical Cushing's syndrome; systematic review.
Copyright: © 2019 Indian Journal of Endocrinology and Metabolism.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.Lancet Diabetes Endocrinol. 2014 May;2(5):396-405. doi: 10.1016/S2213-8587(13)70211-0. Epub 2014 Jan 29. Lancet Diabetes Endocrinol. 2014. PMID: 24795253
-
Clinical Characteristics and Metabolic Features of Patients with Adrenal Incidentalomas with or without Subclinical Cushing's Syndrome.Endocrinol Metab (Seoul). 2014 Dec 29;29(4):457-63. doi: 10.3803/EnM.2014.29.4.457. Epub 2014 May 27. Endocrinol Metab (Seoul). 2014. PMID: 25325264 Free PMC article.
-
Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.J Clin Endocrinol Metab. 2000 Apr;85(4):1440-8. doi: 10.1210/jcem.85.4.6515. J Clin Endocrinol Metab. 2000. PMID: 10770179
-
Subclinical Cushing's syndrome.Endocrinol Metab Clin North Am. 2000 Mar;29(1):43-56. doi: 10.1016/s0889-8529(05)70115-8. Endocrinol Metab Clin North Am. 2000. PMID: 10732263 Review.
-
Comparison of adrenalectomy with conservative treatment on mild autonomous cortisol secretion: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2024 May 13;15:1374711. doi: 10.3389/fendo.2024.1374711. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38808111 Free PMC article.
Cited by
-
The heart-brain axis: A proteomics study of meditation on the cardiovascular system of Tibetan Monks.EBioMedicine. 2022 Jun;80:104026. doi: 10.1016/j.ebiom.2022.104026. Epub 2022 May 13. EBioMedicine. 2022. PMID: 35576643 Free PMC article.
-
Evaluation of Cardiometabolic Risk in Patients with Non-Functioning Adrenal Adenomas Using the Systematic Coronary Risk Evaluation 2 (SCORE2) and the Systematic Coronary Risk Evaluation 2-Older Persons (SCORE2-OP) Algorithms.Med Sci Monit. 2024 Nov 27;30:e945899. doi: 10.12659/MSM.945899. Med Sci Monit. 2024. PMID: 39600070 Free PMC article.
-
Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches.Nat Rev Endocrinol. 2024 Aug;20(8):460-473. doi: 10.1038/s41574-024-00984-y. Epub 2024 Apr 22. Nat Rev Endocrinol. 2024. PMID: 38649778 Review.
-
Is there a role for the IGF system and epidermal growth factor (EGF) in the pathogenesis of adrenocortical adenomas? A preliminary case-control study.Physiol Res. 2020 Dec 22;69(6):1085-1094. doi: 10.33549/physiolres.934553. Epub 2020 Nov 19. Physiol Res. 2020. PMID: 33210933 Free PMC article.
-
Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas.Cureus. 2020 Jan 6;12(1):e6574. doi: 10.7759/cureus.6574. Cureus. 2020. PMID: 32051792 Free PMC article.
References
-
- Peppa M, Boutati E, Koliaki C, Papaefstathiou N, Garoflos E, Economopoulos T, et al. Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: A cause-effect relationship? Metabolism. 2010;59:1435–41. - PubMed
-
- Terzolo M, Pia A, Ali A, Osella G, Reimondo G, Bovio S, et al. Adrenal incidentaloma: A new cause of the metabolic syndrome? J Clin Endocrinol Metab. 2002;87:998–1003. - PubMed
-
- Zhang W, Tang ZY, Wang WQ, Ning G. Metabolic syndrome inpatients with adrenocortical adenoma. Zhonghua Yi Xue Za Zhi. 2006;86:3397–400. - PubMed
-
- Peppa M, Koliaki C, Raptis SA. Adrenal incidentalomas and cardiometabolic morbidity: An emerging association with serious clinical implications. J Intern Med. 2010;268:555–66. - PubMed
-
- Reincke M, Fassnacht M, Vath S, Mora P, Allolio B. Adrenal incidentalomas: A manifestation of the metabolic syndrome? Endocr Res. 1996;22:757–61. - PubMed